审计服务独立性与客观性

Search documents
上海第一医药股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-19 19:00
Group 1 - The company plans to appoint a new accounting firm, Shanghai Huikai Accounting Firm (Special General Partnership), for the 2025 financial report audit due to the previous auditor, Lixin Accounting Firm (Special General Partnership), reaching the maximum service duration as per regulations [4][16][19] - The new accounting firm, Huikai, was established in 2013 and has 112 partners and 553 certified public accountants, with a total of over 1,900 employees [5][6] - In 2024, Huikai's audited business revenue was 683 million RMB, with audit service revenue of 479 million RMB and securities service revenue of 204 million RMB [6][8] Group 2 - The company has confirmed that there are no disputes regarding the change of accounting firms, and both the previous and new firms have agreed to the transition [17] - The audit fee for the 2025 financial report is set at 700,000 RMB, a decrease of 2.78% from the previous year's fee of 720,000 RMB [15][14] - The board of directors approved the appointment of Huikai with a unanimous vote of 9 in favor, with no objections or abstentions [20][53] Group 3 - The company will hold its second extraordinary general meeting on September 4, 2025, to discuss the appointment of the new accounting firm [57] - The meeting will be conducted both in-person and online, allowing shareholders to vote through the Shanghai Stock Exchange's network voting system [58][59] - The company has ensured that all necessary legal and procedural requirements for the meeting have been met [26][66]